How much funding has Osanni Bio raised?

Osanni Bio has raised $230.0M in total funding, most recently a venture unknown round.

Who are Osanni Bio's investors?

Osanni Bio's investors include Invus Opportunities.

When was Osanni Bio founded?

Osanni Bio was founded in 2023.

Where is Osanni Bio headquartered?

Osanni Bio is headquartered in San Francisco, California, United States.

What industry is Osanni Bio in?

Osanni Bio operates in Biotech, Healthcare.

How many employees does Osanni Bio have?

Osanni Bio has 11-50 employees.

Osanni Bio

San Francisco, United States · Founded 2023 · $230.0M raised

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 11–50
Founded: 2023
Business Model: B2B

Website: osanni.bio
Total Funding: $230.0M
Last Round: $190.0M Venture RoundJun 2026
Rounds: 2

About

Osanni Bio is a San Francisco-based development-stage therapeutics company that applies a biodesign-driven innovation engine to discover and develop novel therapies in ophthalmology and cardiology. The company's model centers on building specialized affiliate spinoff companies around validated drug targets, funded with $190 million in Series B financing led by Patient Square Capital.

Summary

Osanni Bio is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $230.0M in total across 2 rounds, most recently a $190.0M Venture Round round in Jun 2026. Investors include Invus Opportunities.